US to end funding of South Africa's HIV programmes over claims of Afrikaner persecution
The United States is ending funding for South Africa's HIV programs, citing concerns over the alleged persecution of the white-minority Afrikaner community. The White House stated that further aid would not be provided due to "unjust and immoral practices," with President Trump having falsely alleged a "white genocide" in South Africa.

Briefing Summary
AI-generatedThe United States is ending funding for South Africa's HIV programs, citing concerns over the alleged persecution of the white-minority Afrikaner community. The White House stated that further aid would not be provided due to "unjust and immoral practices," with President Trump having falsely alleged a "white genocide" in South Africa. This decision impacts PEPFAR funding, which previously supplied about a fifth of the country's HIV program spending. A US State Department official confirmed a phased drawdown of PEPFAR funds due to South Africa's failure to meet policy requests. The US government aims to foster self-reliance, noting South Africa's status as a middle-income country capable of supporting its own health programs. South Africa's health ministry maintains that antiretroviral drug provision is funded separately, primarily by the government.
Article analysis
Model · rule-basedKey claims
5 extractedPepfar contributed to the country's HIV programme, but antiretroviral drugs were funded separately, mostly by the government.
Pepfar funding, which had been providing about a fifth of South Africa's total spending on HIV programmes, would see a phased drawdown.
South Africa is a middle-income country and is more than capable of supporting its own health programs.
US to end funding of South Africa's HIV programmes over claims of Afrikaner persecution.
Trump has falsely alleged that there is a 'white genocide' taking place in South Africa.